期刊文献+

胃癌淋巴结包膜周侵犯与预后关系

Gastric Cancer Lymph Node Capsule Weeks Infringement Relationship with Prognosis
下载PDF
导出
摘要 目的:探讨胃癌淋巴结包膜周侵犯与预后的关系。方法:选取2010年3月至2016年3月于乐昌市第二人民医院就诊收治并确诊为胃癌的患者中随机抽出50例淋巴结包膜周侵犯患者为观察组,抽取30例未发生淋巴结包膜周侵犯的患者作为对照组,获取足够数量的胃癌切除时转移的淋巴结,分析胃癌淋巴结包膜周侵犯与预后的关系。结果:观察组患者术后平均生存时间(34.73±2.45)月,对照组患者术后平均生存时间(55.13±2.58)月,差异具有统计学意义(P<0.05)。而观察组患者与对照组患者相比,肿瘤的分期越高,预后的生存时间越短,差异具有统计学意义(P<0.05)。结论:胃癌淋巴结包膜周侵犯呈现阳性的患者,其肿瘤的分期更高,远处转移的发生率也更高,预后效果更差,复发率更高。 Objective To discuss the relationship between gastric cancer lymph node capsule weeks invasion and prognosis. Methods From March 2010 to March 2016 in our hospital were analyzed and diagnosed with stomach cancer patients randomly take out 50 patients with capsule weeks infringement as the experimental group,the extraction of 30 patients with capsule weeks infringement didn't happen as control group,to obtain a sufficient number of gastric cancer resection of metastasis of lymph nodes,analyzed the relationship between the prognosis of gastric cancer invasion,and lymph node capsule weeks. Result Experimental group patients postoperative average survival time was(34.73+ 2.45) month,control group patients postoperative average survival time was(55.13+2.58) month,data difference,P〈0.05,with statistical significance. Compared with the control group and experimental group patients,the higher the tumor staging and prognosis of shorter survival time,the comparison of data in statistically significant,P〈0.05). Conclusion Patients with gastric cancer lymph node capsule weeks positive infringement,the tumor staging is higher,the incidence of distant metastases is also higher,poorer prognosis effect,the recurrence rate is higher.
作者 廖茂成 LIA(The Second People's Hospital of Lechang City, Guangdong Lechang 512229)
出处 《深圳中西医结合杂志》 2016年第24期15-16,共2页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
关键词 胃癌 淋巴结 包膜周侵犯 预后 Gastric cancer Lymph nodes Coated weeks infringement The prognosis
  • 相关文献

参考文献4

二级参考文献24

  • 1詹友庆,孙晓卫,李威,陈映波,徐立,关远祥,李元方,徐大志.影响根治术后胃癌预后的多因素分析[J].癌症,2005,24(5):596-599. 被引量:63
  • 2李凯,徐惠绵,陈峻青.淋巴结转移率和数量分级与胃癌预后及病理因素关系的研究[J].中华医学杂志,2005,85(30):2113-2116. 被引量:25
  • 3李景武,梁寒,王晓娜.814例胃癌患者的预后因素分析[J].中国肿瘤临床,2006,33(7):399-402. 被引量:37
  • 4赵刚,詹文华,彭俊生,马晋平,严燕国,何裕隆,董文广,汪建平.进展期胃印戒细胞癌患者的临床病理特点与预后[J].中华普通外科杂志,2006,21(4):251-253. 被引量:13
  • 5许化溪.肿瘤免疫及其免疫检测.见:王兰兰主编.临床免疫学和免疫检验[M].北京:人民卫生出版社,2003:327-339.
  • 6Ohshio G,Manabe T,Watanabe Y,et al.Comparative studies of DU-PAN-2,carcinoembryonic antigen,and CA19-9 in the serum and bile of patients with pancreatic and biliary tract disease:evaluation of the influence of obstructive jaundice[J].Am J Gastroenterol,1990,85(10):1370-1376.
  • 7Watanade M,Chigusa M,Takahashi H,et al.High level of CA19-9,CA50 and CEA-Producible human cholangio carcinoma cell line changes in the secretion ratios in vitro or in vivo.In vitro Cell Dev Biol Anim,2000,36:104.
  • 8陈瑜,王磊,赵允文.血清CA19-9的酶免测定及临床应用[J].中国肿瘤临床,1997,24(6):408-410. 被引量:25
  • 9王觉生.诊断性试验证据的严格评价[M]。见:王家良主编 21世纪的临床医学-循证医学 北京:人民卫生出版社2001:62-73.
  • 10Sarela AI, Turnbull AD, Coit DG, et al. Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenoearcinoma[J]. Ann Surg Oncol, 2003, 10(7):783-791.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部